Supplemental material
Pathogens and Global Health
Volume 116, 2022 - Issue 2
Review
Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
Federico Martinón-Torresa Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP, Instituto De Investigación Sanitaria De Santiago and Universidad De Santiago De Compostela (Usc), Santiago de Compostela, Galicia, Spain
https://orcid.org/0000-0002-9023-581XView further author information
https://orcid.org/0000-0002-9023-581XView further author information, Muhamed-Kheir Tahab Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, Francehttps://orcid.org/0000-0002-0716-3174View further author information
https://orcid.org/0000-0002-0716-3174View further author information, , Victoria Abbing-Karahagopiand GSK, Amsterdam, The Netherlandshttps://orcid.org/0000-0003-1987-363XView further author information
https://orcid.org/0000-0003-1987-363XView further author information, Michele Pellegrinie GSK, Siena, Italyhttps://orcid.org/0000-0001-8505-9260View further author information
https://orcid.org/0000-0001-8505-9260View further author information, Rafik Bekkat-Berkanif GSK, Rockville, MD, United Stateshttps://orcid.org/0000-0003-0683-6055View further author information
https://orcid.org/0000-0003-0683-6055View further author information & Véronique Abitbolg GSK, Rueil-Malmaison, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-0369-7715View further author information
https://orcid.org/0000-0003-0369-7715View further author information show all